Salvatore Calabrese serves as Executive at Gain Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Salvatore Calabrese has executed 2 insider transactions totaling $24.3M, demonstrating a bullish approach to their equity position. Their most recent transaction on May 19, 2022 involved purchasing 3,000 shares valued at $24.3M.
Salvatore Calabrese currently holds 3,000 shares of Gain Therapeutics, Inc. (GANX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Salvatore Calabrese has been a net buyer of GANX stock. They have purchased $24.3M and sold $0 worth of shares.
Salvatore Calabrese's most recent insider trade was on May 19, 2022, when they purchased 3,000 shares at $8100.00 per share.
Get notified when new Form 4 filings are submitted
| $2.70 |
| Discretionary |